The role of immune checkpoints in cardiovascular disease

por Yousif, Laura I., Tanja, Anniek A., de Boer, Rudolf A., Teske, Arco J., Meijers, Wouter C.
Publicado 2022

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities

por Yousif, Laura I., Screever, Elles M., Versluis, Daniëlle, Aboumsallem, Joseph Pierre, Nierkens, Stefan, Manintveld, Olivier C., de Boer, Rudolf A., Meijers, Wouter C.
Publicado 2023

Circulating immune checkpoints predict heart failure outcomes

por Screever, Elles M., Yousif, Laura I.E., Moslehi, Javid J., Salem, Joe‐Elie, Voors, Adriaan A., Silljé, Herman H.W., de Boer, Rudolf A., Meijers, Wouter C.
Publicado 2023

LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review

por Printezi, Markella I., Yousif, Laura I. E., Kamphuis, Janine A. M., van Laake, Linda W., Cramer, Maarten J., Hobbelink, Monique G. G., Asselbergs, Folkert W., Teske, Arco J.
Publicado 2022

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure

por van den Berg, Pieter F., Aboumsallem, Joseph Pierre, Screever, Elles M., Shi, Canxia, de Wit, Sanne, Bracun, Valentina, Yousif, Laura I., Geerlings, Lotte, Wang, Dongyu, Ho, Jennifer E., Bakker, Stephan J.L., van der Vegt, Bert, Silljé, Herman H.W., de Boer, Rudolf A., Meijers, Wouter C.
Publicado 2023

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

por Engelen, Suzanne E., Ververs, Francesca A., Markovska, Angela, Lagerholm, B. Christoffer, Kraaijenhof, Jordan M., Yousif, Laura I.E., Zurke, Yasemin-Xiomara, Gulersonmez, Can M.C., Kooijman, Sander, Goddard, Michael, van Eijkeren, Robert J., Jervis, Peter J., Besra, Gurdyal S., Haitjema, Saskia, Asselbergs, Folkert W., Kalkhoven, Eric, Ploegh, Hidde L., Boes, Marianne, Cerundolo, Vincenzo, Hovingh, G.K., Salio, Mariolina, Stigter, Edwin C.A., Rensen, Patrick C.N., Monaco, Claudia, Schipper, Henk S.
Publicado 2023